Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21WAF1/CIP1

被引:0
|
作者
Yang, F
von Knethen, A
Brüne, B
机构
[1] Univ Erlangen Nurnberg, Fac Med, Dept Med 4, Expt Div, D-91054 Erlangen, Germany
[2] Fourth Mil Med Univ, Dept Pathol, Xian 710032, Peoples R China
关键词
p21(WIF1/CIP1); p53; NO; apoptosis; cell cycle; macrophages;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
When produced in excess, the inflammatory mediator nitric oxide (NO) attenuates cell-cycle progression at the G1 phase in tight correlation with p21(WAF1/CIP1) expression, provokes accumulation of the tumor suppressor p53, and initiates apoptosis/necrosis as judged on cell accumulation in the sub-G1 phase, To verify the role of p21(WAF1/CIP1) in modulating cell-cycle arrest vs. apoptosis, we transfected stably antisense p21(WAF1/CIP1)-encoding plasmids, Following NO exposure, accummulation of p21(WAF1/CIP1), but not p53, was largely attenuated in antisense p21(WAF1/CIP1) tansfectants. Moreover, the G1 cell-cycle arrest was abrogated, and cells were sensitized toward apoptosis compared with parent macrophages, In contrast, antisense elimination of p53 attenuated p53 as well as p21(WAF1/CIP1) expression, abolished the G1 cell-cycle arrest, and prevented apoptosis. We conclude that p21(WAF1/CIP1) is a downstream target of p53 in macrophages that modulate the sensitivity toward the immune-modulator NO.
引用
收藏
页码:916 / 922
页数:7
相关论文
共 50 条
  • [1] Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression
    Kralj, M
    Husnjak, K
    Körbler, T
    Pavelic, J
    CANCER GENE THERAPY, 2003, 10 (06) : 457 - 467
  • [2] Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression
    Marijeta Kralj
    Koraljka Husnjak
    Tajana Körbler
    Jasminka Pavelić
    Cancer Gene Therapy, 2003, 10 : 457 - 467
  • [3] p21Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells
    Myriam Gorospe
    Corrado Cirielli
    Xiantao Wang
    Prem Seth
    Maurizio C Capogrossi
    Nikki J Holbrook
    Oncogene, 1997, 14 : 929 - 935
  • [4] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    De la Cueva, E.
    Garcia-Cao, I.
    Herranz, M.
    Lopez, P.
    Garcia-Palencia, P.
    Flores, J. M.
    Serrano, M.
    Fernandez-Piqueras, J.
    Martin-Caballero, J.
    ONCOGENE, 2006, 25 (29) : 4128 - 4132
  • [5] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    E De la Cueva
    I García-Cao
    M Herranz
    P López
    P García-Palencia
    J M Flores
    M Serrano
    J Fernández-Piqueras
    J Martín-Caballero
    Oncogene, 2006, 25 : 4128 - 4132
  • [6] p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
    Susan Nozell
    Xinbin Chen
    Oncogene, 2002, 21 : 1285 - 1294
  • [7] p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
    Nozell, S
    Chen, XB
    ONCOGENE, 2002, 21 (08) : 1285 - 1294
  • [8] p21WAF1/CIP1 and cancer: A shifting paradigm?
    Gartel, Andrei L.
    BIOFACTORS, 2009, 35 (02) : 161 - 164
  • [9] p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis
    Park, YN
    Chae, KJ
    Kwon, KW
    Oh, BK
    Lee, KS
    Lee, WJ
    Park, C
    HEPATO-GASTROENTEROLOGY, 2003, 50 (53) : 1292 - 1296
  • [10] POST-TRANSCRIPTIONAL REGULATION OF P21WAF1/CIP1 BY P53
    季加孚
    张霁
    焦春雨
    顾晋
    谭立新
    张平
    李培详
    Chinese Journal of Cancer Research, 2001, (02) : 35 - 39